Lundbeck ups guidance, shifts jobs in restructure
This article was originally published in Scrip
Lundbeck has upped its financial guidance for 2013 and given details of its rationalization program, which will hit 180-200 jobs as the firm restructures European business services and sets up a dedicated center in Poland. The company's 'Fit for the Future' program, which will run from 2013-2015, is expected to deliver an annual benefit of at least DKK500m ($90m) from 2016.
You may also be interested in...
GlamorousAI is developing technology to uncover new targets and take on previously intractable disease challenges. Founder Noor Shaker hopes to license a drug to big pharma within the next three years.
INFOGRAPHIC: In 2019, 10 blockbuster medicines booked combined sales of $92.5bn. This infographic examines those drugs that commanded the greatest revenues globally, and answers some key questions. Which therapeutic areas include the most lucrative blockbusters? Which companies enjoyed their spoils? And which drugs were new to the top 10 last year? It also takes a look at the position of these products on the all-important US market.
Fundraising in the life sciences sector has been booming even as firms in many other industries are struggling to stay in business. Goodwin’s David Mardle is upbeat about the sector’s ongoing prospects – although M&A deals are currently proving tricky to complete.